Skip to content

Clinical trials

Hyperphosphatemia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20075
20081
20091
20111
20133
20142
20161
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated5
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation7
Ineos Healthcare Limited3
Ardelyx1
Fresenius Medical Care Deutschland GmbH1
Genzyme, a Sanofi Company1
Great Ormond Street Hospital for Children NHS Foundation Trust1
Novartis Pharmaceuticals1
Shire1
The University of Queensland1
Vifor Fresenius Medical Care Renal Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia18
Renal Insufficiency, Chronic10
Kidney Failure, Chronic6
Chronic Kidney Disease-Mineral and Bone Disorder1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.